1887

Chapter 14 : Otitis Media

MyBook is a cheap paperback edition of the original book and will be sold at uniform, low price.

Preview this chapter:
Zoom in
Zoomout

Otitis Media, Page 1 of 2

| /docserver/preview/fulltext/10.1128/9781555817947/9781555812447_Chap14-1.gif /docserver/preview/fulltext/10.1128/9781555817947/9781555812447_Chap14-2.gif

Abstract:

In all areas of the world, upper respiratory tract (URT) infections and their complicating sequelae are the leading causes of acute infectious morbidity. Otitis media (OM), or inflammation of the middle ear, is one of these complicating sequelae of URT infections and is indeed a major health care concern of childhood. This chapter discusses OM’s etiologic agents, animal models, and mechanisms of pathogenesis. Multiple mechanisms have been identified that serve as contributing factors in the synergistic relationship between the URT viruses and the primary bacterial pathogens of OM, and while each of these is a highly specific effect, all fall within the general category of compromise of airway defenses. The chapter reviews some of these mechanisms, such as viral effects on bacterial adherence and/or colonization, antibiotic efficacy, host immune functions, and rheological properties of mucus and mucociliary transport. We are continually adapting our treatment regimens for OM on the basis of newly acquired information and our improved understanding of the molecular mechanisms behind the pathogenesis of middle ear infections. Some of the ways this increased understanding has led to changes in our approaches to treat and/or prevent OM are reviewed. Good clinical evidence exists to believe that by eradicating the predisposing viral infection, one could have a significant effect on prevention of bacterial OM. Vaccine or treatment strategies that effectively inhibit the initial establishment of infection in the middle ear cleft will be particularly important in this regard.

Citation: Bakaletz L. 2002. Otitis Media, p 259-298. In Brogden K, Guthmiller J (ed), Polymicrobial Diseases. ASM Press, Washington, DC. doi: 10.1128/9781555817947.ch14

Key Concept Ranking

Infection and Immunity
0.47523966
Tumor Necrosis Factor alpha
0.43312988
Influenza B virus
0.4185895
0.47523966
Highlighted Text: Show | Hide
Loading full text...

Full text loading...

Figures

Image of FIGURE 1
FIGURE 1

Number of patients per month with AOM ( = 4,524) (a) and respiratory virus infections (b to f ) during a 6-year study in the Turku University Hospital (Turku, Finland). (b) All virus infections ( = 961); (c) respiratory syncytial virus ( = 472); (d) adenovirus (= 197); (e) parainfluenza virus types 1, 2, and 3 (= 176); (f ) influenza A (unshaded) and influenza B (gray) viruses ( = 116). (Reprinted from [ ] with permission of the publisher.)

Citation: Bakaletz L. 2002. Otitis Media, p 259-298. In Brogden K, Guthmiller J (ed), Polymicrobial Diseases. ASM Press, Washington, DC. doi: 10.1128/9781555817947.ch14
Permissions and Reprints Request Permissions
Download as Powerpoint
Image of FIGURE 2
FIGURE 2

(A) Cumulative percentage of 38 ears (19 chinchillas) developing OME after i.n. inoculation of type 7F All ears with effusion yielded pneumococci on culture. (B) Cumulative percentage of 72 ears (36 chinchillas) developing OME and without effusion after i.n. inoculation of type 7F and influenza A virus. Symbols: ●, animals with pneumococcal OME; Δ, animals with pneumococcal and other culture-positive OME (other bacteria included [1 ear] and species [1 ear]); □, animals with culturepositive as well as sterile OME; ○, animals with all types of OME and OM without effusion. (Both panels are reprinted from [ ] with permission of the publisher.)

Citation: Bakaletz L. 2002. Otitis Media, p 259-298. In Brogden K, Guthmiller J (ed), Polymicrobial Diseases. ASM Press, Washington, DC. doi: 10.1128/9781555817947.ch14
Permissions and Reprints Request Permissions
Download as Powerpoint
Image of FIGURE 3
FIGURE 3

Adherence of NTHI to chinchilla eustachian tube floor (a) or roof (b) mucus during AV infection. Symbols: ●, pharyngeal; ▪, mid-Eustachian tube; ▲, tympanic portion; *, significant difference compared with same day, same portion of ET roof, µ 0.05.) (c) Adherence of NTHI to chinchilla middle ear mucosal epithelium during adenovirus infection. (All panels are reprinted from [ ] with permission of the publisher.) Error bars indicate deviations.

Citation: Bakaletz L. 2002. Otitis Media, p 259-298. In Brogden K, Guthmiller J (ed), Polymicrobial Diseases. ASM Press, Washington, DC. doi: 10.1128/9781555817947.ch14
Permissions and Reprints Request Permissions
Download as Powerpoint
Image of FIGURE 4
FIGURE 4

Histographic representation of number of A549 cells ( axis) expressing red fluorescence of PKH-26-labeled NTHI ( axis), as determined by flow cytometry (A549:NTHI = 1:100). (A) Background fluorescence of RSV-exposed (multiplicity of infection = 1, 24 h) or control A549 cells; (B and C) fluorescence of NTHI and NTHI attached to control or pRSV-exposed A549 cells. (Reprinted from [ ] with permission of the publisher.)

Citation: Bakaletz L. 2002. Otitis Media, p 259-298. In Brogden K, Guthmiller J (ed), Polymicrobial Diseases. ASM Press, Washington, DC. doi: 10.1128/9781555817947.ch14
Permissions and Reprints Request Permissions
Download as Powerpoint
Image of FIGURE 5
FIGURE 5

Comparison of nasopharyngeal carriage of nontypeable and in normal (□) and otitis-prone (▨) children during health (A) and during upper respiratory tract illness (B). , < 0.05; , < 0.001 ( ). (Reprinted from the [ ] with permission of the publisher.)

Citation: Bakaletz L. 2002. Otitis Media, p 259-298. In Brogden K, Guthmiller J (ed), Polymicrobial Diseases. ASM Press, Washington, DC. doi: 10.1128/9781555817947.ch14
Permissions and Reprints Request Permissions
Download as Powerpoint
Image of FIGURE 6
FIGURE 6

Anatomy of the Eustachian tube and middle ear system. (Reprinted from [ ] with permission of the publisher.)

Citation: Bakaletz L. 2002. Otitis Media, p 259-298. In Brogden K, Guthmiller J (ed), Polymicrobial Diseases. ASM Press, Washington, DC. doi: 10.1128/9781555817947.ch14
Permissions and Reprints Request Permissions
Download as Powerpoint
Image of FIGURE 7
FIGURE 7

Eustachian tube lumen on day 5 (a and b) and day 10 (c and d) after i.n. influenza virus inoculation showing mucoid secretions and cellular debris (hematoxylin and eosin stain; original magnification, ×400). (Reprinted from [ ] with permission of the publisher.)

Citation: Bakaletz L. 2002. Otitis Media, p 259-298. In Brogden K, Guthmiller J (ed), Polymicrobial Diseases. ASM Press, Washington, DC. doi: 10.1128/9781555817947.ch14
Permissions and Reprints Request Permissions
Download as Powerpoint
Image of FIGURE 8
FIGURE 8

Occurrence of AOM after the onset of URI in 250 episodes. Bar, number of cases on each day; line, cumulative force of morbidity. (Reprinted from [ ] with permission of the publisher.)

Citation: Bakaletz L. 2002. Otitis Media, p 259-298. In Brogden K, Guthmiller J (ed), Polymicrobial Diseases. ASM Press, Washington, DC. doi: 10.1128/9781555817947.ch14
Permissions and Reprints Request Permissions
Download as Powerpoint
Image of FIGURE 9
FIGURE 9

Ciliary beat frequency of chinchilla Eustachian tube epithelium at sites near the tympanic or pharyngeal orifice following inoculation of influenza A virus. *, significant difference ( ≤ 0.01) from control. Error bars indicate standard deviations. (A) Transbullar inoculation; (B) i.n. inoculation. (Reprinted from [ ] with permission of the publisher.)

Citation: Bakaletz L. 2002. Otitis Media, p 259-298. In Brogden K, Guthmiller J (ed), Polymicrobial Diseases. ASM Press, Washington, DC. doi: 10.1128/9781555817947.ch14
Permissions and Reprints Request Permissions
Download as Powerpoint
Image of FIGURE 10
FIGURE 10

Light micrographs of chinchilla Eustachian tube epithelium after i.n. inoculation of influenza A virus (original magnification, ×64). (A) Two days postinoculation, tympanic site. (B) At 4 days, pharyngeal site. Note focal loss of ciliated cells. (C) At 10 days, pharyngeal site. Note short, regenerating cilia. (D) At 28 days, pharyngeal site. Note normal appearance of epithelium. (Reprinted from [ ] with permission of the publisher.)

Citation: Bakaletz L. 2002. Otitis Media, p 259-298. In Brogden K, Guthmiller J (ed), Polymicrobial Diseases. ASM Press, Washington, DC. doi: 10.1128/9781555817947.ch14
Permissions and Reprints Request Permissions
Download as Powerpoint
Image of FIGURE 11
FIGURE 11

(A) Change over time in ciliary activity of Eustachian tube mucosal epithelium after i.n. inoculation of AV type 1. Data represent means and standard deviations of at least 30 readings. (B) Change over time in ability of Eustachian tube to transport dye after i.n. inoculation of AV type 1. (Both panels are reprinted from [ ] with permission of the publisher.)

Citation: Bakaletz L. 2002. Otitis Media, p 259-298. In Brogden K, Guthmiller J (ed), Polymicrobial Diseases. ASM Press, Washington, DC. doi: 10.1128/9781555817947.ch14
Permissions and Reprints Request Permissions
Download as Powerpoint
Image of FIGURE 12
FIGURE 12

Cross-sections in mid-Eustachian tube 14 days after intranasal inoculation. (a) Note many vacuolated epithelial cells (vac) and those demonstrating late stages of intranuclear inclusions typical of AV. (b) Note marked goblet cell (*) hyperplasia. Bars = 50 µm. (Reprinted from [ ] with permission of the publisher.)

Citation: Bakaletz L. 2002. Otitis Media, p 259-298. In Brogden K, Guthmiller J (ed), Polymicrobial Diseases. ASM Press, Washington, DC. doi: 10.1128/9781555817947.ch14
Permissions and Reprints Request Permissions
Download as Powerpoint
Image of FIGURE 13
FIGURE 13

(A) Percentage of nasal lavage specimens that were culture positive for NTHI in AV-compromised chinchillas that received either saline (shamimmunized) or antisera directed against one of two adhesin-based immunogens [LB1 or LPD-LB1 (f)] by passive transfer prior to i.n. challenge with either of two strains of NTHI (86-028NP or 1885MEE). (B) Percentage of ears that developed OM within each cohort of animals depicted in A. (Both panels are reprinted from [ ] with permission of the publisher.)

Citation: Bakaletz L. 2002. Otitis Media, p 259-298. In Brogden K, Guthmiller J (ed), Polymicrobial Diseases. ASM Press, Washington, DC. doi: 10.1128/9781555817947.ch14
Permissions and Reprints Request Permissions
Download as Powerpoint

References

/content/book/10.1128/9781555817947.chap14
1. Abramson, J. S.,, G. S. Giebink,, E. L. Mills,, and P. G. Quie. 1981. Polymorphonuclear leukocyte dysfunction during influenza virus infection in chinchillas. J. Infect. Dis. 143: 836 845.
2. Abramson, J. S.,, and J. G. Wheeler. 1994. Virus-induced neutrophil dysfunction: role in the pathogenesis of bacterial infections. Pediatr. Infect. Dis. J. 13: 643 652.
3. Alsarraf, R.,, C. J. Jung,, J. Perkins,, C. Crowley,, N. W. Alsarraf,, and G. A. Gates. 1999. Measuring the indirect and direct costs of acute otitis media. Arch. Otolaryngol. Head Neck Surg. 125: 12 18.
4. Anderson, L. J. 2000. Respiratory syncytial virus vaccines for otitis media. Vaccine 19( Suppl. 1): S59 S65.
5. Arola, M.,, O. Ruuskanen,, T. Ziegler,, J. Mertsola,, K. Nanto-Salonen,, A. Putto-Laurila,, M. K. Viljanen,, and P. Halonen. 1990. Clinical role of respiratory virus infection in acute otitis media. Pediatrics. 86: 848 855.
6. Arola, M.,, T. Ziegler,, H. Puhakka,, O. P. Lehtonen,, and O. Ruuskanen. 1990. Rhinovirus in otitis media with effusion. Ann. Otol. Rhinol. Laryngol. 99: 451 453.
7. Arola, M.,, T. Ziegler,, and O. Ruuskanen. 1990. Respiratory virus infection as a cause of prolonged symptoms in acute otitis media. J. Pediatr. 116: 697 701.
8. Arva, E.,, and B. Andersson. 1999. Induction of phagocyte-stimulating and Th1-promoting cytokines by in vitro stimulation of human peripheral blood mononuclear cells with Streptococcus pneumoniae. Scand. J. Immunol. 49: 417 423.
9. Arva, E.,, and B. Andersson. 1999. Induction of phagocyte-stimulating cytokines by in vitro stimulation of human peripheral blood mononuclear cells with Haemophilus influenzae. Scand. J. Immunol. 49: 411 416.
10. Aul, J. J.,, K. W. Anderson,, R. M. Wadowsky,, W. J. Doyle,, L. A. Kingsley,, J. C. Post,, and G. D. Ehrlich. 1998. Comparative evaluation of culture and PCR for the detection and determination of persistence of bacterial strains and DNAs in the Chinchilla laniger model of otitis media. Ann. Otol. Rhinol. Laryngol. 107: 508 513.
11. Bakaletz, L.,, S. R. Griffith,, and D. J. Lim,. 1988. Effect of prostaglandin E2 and bacterial endotoxin on the rate of dye transport in the chinchilla eustachian tube, p. 99 102. In D. J. Lim,, C. D. Bluestone,, J. O. Klein,, and J. D. Nelson (ed.), Proceedings of the Fourth International Symposium on Recent Advances in Otitis Media. B. C. Decker Inc., Toronto, Ontario, Canada..
12. Bakaletz, L. O. 1995. Viral potentiation of bacterial superinfection of the respiratory tract. Trends Microbiol. 3: 110 114.
13. Bakaletz, L. O.,, R. L. Daniels,, and D. J. Lim. 1993. Modeling adenovirus type 1-induced otitis media in the chinchilla: effect on ciliary activity and fluid transport function of eustachian tube mucosal epithelium. J. Infect. Dis. 168: 865 872. ( Erratum, 168:1605, 1993.).
14. Bakaletz, L. O.,, T. M. Hoepf,, T. F. De- Maria,, and D. J. Lim. 1988. The effect of antecedent influenza A virus infection on the adherence of Hemophilus influenzae to chinchilla tracheal epithelium. Am. J. Otolaryngol. 9: 127 134.
15. Bakaletz, L. O.,, and K. A. Holmes. 1997. Evidence for transudation of specific antibody into the middle ears of parenterally immunized chinchillas after an upper respiratory tract infection with adenovirus. Clin. Diagn. Lab. Immunol. 4: 223 225.
16. Bakaletz, L. O.,, B. J. Kennedy,, L. A. Novotny,, G. Dequesne,, J. Cohen,, and Y. Lobet. 1999. Protection against development of otitis media induced by nontypeable Haemophilus influenzae by both active and passive immunization in a chinchilla model of virus-bacterium superinfection. Infect. Immun. 67: 2746 2762.
17. Bakaletz, L. O.,, D. M. Murwin,, and J. M. Billy. 1995. Adenovirus serotype 1 does not act synergistically with Moraxella (Branhamella) catarrhalis to induce otitis media in the chinchilla. Infect. Immun. 63: 4188 4190.
18. Bakaletz, L. O.,, G. J. White,, J. C. Post,, and G. D. Ehrlich. 1998. Blinded multiplex PCR analyses of middle ear and nasopharyngeal fluids from chinchilla models of single- and mixedpathogen- induced otitis media. Clin. Diagn. Lab. Immunol. 5: 219 224.
19. Baldwin, R. L. 1993. Effects of otitis media on child development. Am. J. Otol. 14: 601 604.
20. Belshe, R. B.,, P. M. Mendelman,, J. Treanor,, J. King,, W. C. Gruber,, P. Piedra,, D. I. Bernstein,, F. G. Hayden,, K. Kotloff,, K. Zangwill,, D. Iacuzio,, and M. Wolff. 1998. The efficacy of live attenuated, cold-adapted, trivalent, intranasal influenza virus vaccine in children. N. Engl. J. Med. 338: 1405 1412.
21. Berman, S.,, R. Roark,, and D. Luckey. 1994. Theoretical cost effectiveness of management options for children with persisting middle ear effusions. Pediatrics 93: 353 363.
22. Black, S.,, H. Shinefield,, B. Fireman,, E. Lewis,, P. Ray,, J. R. Hansen,, L. Elvin,, K. M. Ensor,, J. Hackell,, G. Siber,, F. Malinoski,, D. Madore,, I. Chang,, R. Kohberger,, W. Watson,, R. Austrian,, K. Edwards, and the Northern California Kaiser Permanente Vaccine Study Center Group. 2000. Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children. Pediatr. Infect. Dis. J. 19: 187 195.
23. Bluestone, C. D. 1996. Pathogenesis of otitis media: role of eustachian tube. Pediatr. Infect. Dis. J. 15: 281 291.
24. Bright, R. A.,, R. M. Moore, Jr.,, L. L. Jeng,, C. M. Sharkness,, S. E. Hamburger,, and P. M. Hamilton. 1993. The prevalence of tympanostomy tubes in children in the United States, 1988. Am. J. Public Health 83: 1026 1028.
25. Brook, I.,, and A. E. Gober. 1999. Resistance to antimicrobials used for therapy of otitis media and sinusitis: effect of previous antimicrobial therapy and smoking. Ann. Otol. Rhinol. Laryngol. 108: 645 647.
26. Buchman, C. A.,, W. J. Doyle,, D. Skoner,, P. Fireman,, and J. M. Gwaltney. 1994. Otologic manifestations of experimental rhinovirus infection. Laryngoscope 104: 1295 1299.
27. Buchman, C. A.,, W. J. Doyle,, D. P. Skoner,, J. C. Post,, C. M. Alper,, J. T. Seroky,, K. Anderson,, R. A. Preston,, F. G. Hayden,, P. Fireman, et al. 1995. Influenza A virus-induced acute otitis media. J. Infect. Dis. 172: 1348 1351.
28. Budhani, R. K.,, and J. K. Struthers. 1998. Interaction of Streptococcus pneumoniae and Moraxella catarrhalis: investigation of the indirect pathogenic role of beta-lactamase-producing moraxellae by use of a continuous-culture biofilm system. Antimicrob. Agents Chemother. 42: 2521 2526.
29. Canafax, D. M.,, Z. Yuan,, T. Chonmaitree,, K. Deka,, H. Q. Russlie,, and G. S. Giebink. 1998. Amoxicillin middle ear fluid penetration and pharmacokinetics in children with acute otitis media. Pediatr. Infect. Dis. J. 17: 149 156.
30. Cantekin, E. I.,, E. M. Mandel,, C. D. Bluestone,, H. E. Rockette,, J. L. Paradise,, S. E. Stool,, T. J. Fria,, and K. D. Rogers. 1983. Lack of efficacy of a decongestant-antihistamine combination for otitis media with effusion (“secretory” otitis media) in children. Results of a double-blind, randomized trial. N. Engl. J. Med. 308: 297 301.
31. Carson, J. L.,, A. M. Collier,, and S. S. Hu. 1985. Acquired ciliary defects in nasal epithelium of children with acute viral upper respiratory infections. N. Engl. J. Med. 312: 463 468.
32. Casselbrant, M. L.,, E. M. Mandel,, P. A. Fall,, H. E. Rockette,, M. Kurs-Lasky,, C. D. Bluestone,, and R. E. Ferrell. 1999. The heritability of otitis media: a twin and triplet study. JAMA 282: 2125 2130.
33. Cassell, G. H. 1997. New and Reemerging Infectious Diseases: a Global Crisis and Immediate Threat to the Nation’s Health: the Role of Research. American Society for Microbiology, Washington, D.C..
34. Cassell, G. H.,, G. L. Archer,, T. R. Beam,, M. J. Gilchrist,, D. Goldmann,, D. C. Hooper,, R. N. Jones,, S. H. Kleven,, J. Lederberg,, S. B. Levy,, D. H. Lein,, R. C. Moellering,, T. F. O’Brien,, B. Osburn,, M. Osterholm,, D. M. Shlaes,, M. Terry,, S. A. Tolin,, and A. Tomasz. 1994. Report of the ASM Task Force on Antibiotic Resistance. American Society for Microbiology, Washington, D.C..
35. Chartrand, S. A.,, and A. Pong. 1998. Acute otitis media in the 1990s: the impact of antibiotic resistance. Pediatr. Ann. 27: 86 95.
36. Chonmaitree, T.,, V. M. Howie,, and A. L. Truant. 1986. Presence of respiratory viruses in middle ear fluids and nasal wash specimens from children with acute otitis media. Pediatrics 77: 698 702.
37. Chonmaitree, T.,, M. J. Owen,, and V. M. Howie. 1990. Respiratory viruses interfere with bacteriologic response to antibiotic in children with acute otitis media. J. Infect. Dis. 162: 546 549.
38. Chonmaitree, T.,, M. J. Owen,, J. A. Patel,, D. Hedgpeth,, D. Horlick,, and V. M. Howie. 1992. Effect of viral respiratory tract infection on outcome of acute otitis media. J. Pediatr. 120: 856 862.
39. Chonmaitree, T.,, M. J. Owen,, J. A. Patel,, D. Hedgpeth,, D. Horlick,, and V. M. Howie. 1992. Presence of cytomegalovirus and herpes simplex virus in middle ear fluids from children with acute otitis media. Clin. Infect. Dis. 15: 650 653.
40. Chonmaitree, T.,, J. A. Patel,, M. A. Lett- Brown,, T. Uchida,, R. Garofalo,, M. J. Owen,, and V. M. Howie. 1994. Virus and bacteria enhance histamine production in middle ear fluids of children with acute otitis media. J. Infect. Dis. 169: 1265 1270.
41. Chonmaitree, T.,, J. A. Patel,, T. Sim,, R. Garofalo,, T. Uchida,, V. M. Howie,, and M. J. Owen. 1996. Role of leukotriene B4 and interleukin- 8 in acute bacterial and viral otitis media. Ann. Otol. Rhinol. Laryngol. 105: 968 974.
42. Chung, M. H.,, R. Enrique,, D. J. Lim,, and T. F. De Maria. 1994. Moraxella (Branhamella) catarrhalis-induced experimental otitis media in the chinchilla. Acta Otolaryngol. 114: 415 422.
43. Chung, M. H.,, S. R. Griffith,, K. H. Park,, D. J. Lim,, and T. F. DeMaria. 1993. Cytological and histological changes in the middle ear after inoculation of influenza A virus. Acta Otolaryngol. (Stockholm) 113: 81 87.
44. Clemans, D. J.,, R. J. Bauer,, J. A. Hanson,, M. V. Hobbs,, J. W. St. Geme III, C. F. Marrs, and J. R. Gilsdorf. 2000. Induction of proinflammatory cytokines from human respiratory epithelial cells after stimulation by nontypeable Haemophilus influenzae. Infect. Immun. 68: 4430 4440.
45. Clements, D. A.,, L. Langdon,, C. Bland,, and E. Walter. 1995. Influenza A vaccine decreases the incidence of otitis media in 6- to 30- monthold children in day care. Arch. Pediatr. Adolesc. Med. 149: 1113 1117.
46. Cohen, R.,, E. Bingen,, E. Varon,, F. de La Rocque,, N. Brahimi,, C. Levy,, M. Boucherat,, J. Langue,, and P. Geslin. 1997. Change in nasopharyngeal carriage of Streptococcus pneumoniae resulting from antibiotic therapy for acute otitis media in children. Pediatr. Infect. Dis. J. 16: 555 560.
47. Cohen, R.,, C. Levy,, M. Boucherat,, J. Langue,, E. Autret,, P. Gehanno,, and F. de La Rocque. 2000. Five vs. ten days of antibiotic therapy for acute otitis media in young children. Pediatr. Infect. Dis. J. 19: 458 463.
48. Costerton, J. W. 1999. Introduction to biofilm. Int. J. Antimicrob. Agents 11: 217 221, 237 239.
49. Costerton, J. W.,, P. S. Stewart,, and E. P. Greenberg. 1999. Bacterial biofilms: a common cause of persistent infections. Science 284: 1318 1322.
50. Culpepper, L.,, and J. Froom. 1997. Routine antimicrobial treatment of acute otitis media: is it necessary? JAMA 278: 1643 1645.
51. Dagan, R.,, E. Leibovitz,, G. Cheletz,, A. Leiberman,, and N. Porat. 2001. Antibiotic treatment in acute otitis media promotes superinfection with resistant Streptococcus pneumoniae carried before initiation of treatment. J. Infect. Dis. 183: 880 886.
52. Daly, K. A.,, J. E. Brown,, B. R. Lindgren,, M. H. Meland,, C. T. Le,, and G. S. Giebink. 1999. Epidemiology of otitis media onset by six months of age. Pediatrics 103: 1158 1166.
53. De, B. K.,, J. S. Sampson,, E. W. Ades,, R. C. Huebner,, D. L. Jue,, S. E. Johnson,, M. Espina,, A. R. Stinson,, D. E. Briles,, and G. M. Carlone. 2000. Purification and characterization of Streptococcus pneumoniae palmitoylated pneumococcal surface adhesin A expressed in Escherichia coli. Vaccine 18: 1811 1821.
54. DeMaria, T. F. 1989. Animal models for nontypable Haemophilus influenzae otitis media. Pediatr. Infect. Dis. J. 8: S40 S42.
55. DeMaria, T. F.,, J. M. Billy,, and D. G. Danahey. 1996. Growth factors during endotoxin- induced otitis media. Acta Otolaryngol. (Stockholm) 116: 854 856.
56. Derecola, A.,, D. L. Butler,, R. L. Kaplan,, L. A. Miller,, and J. A. Poupard. 1999. A 5-year surveillance study of 44,691 isolates of Haemophilus influenzae project Beta-Alert 1993-1997. Antimicrob. Agents Chemother. 43: 185 186.
57. Dowell, S. F.,, S. M. Marcy,, W. R. Phillips,, M. A. Gerber,, and B. Schwartz. 1998. Otitis media: principles of judicious use of antimicrobial agents. Pediatrics 101: 165 171.
58. Doyle, W. J. 1989. Animal models of otitis media: other pathogens. Pediatr. Infect. Dis. J. 8: S45 S47.
59. Doyle, W. J.,, D. P. Skoner,, F. Hayden,, C. A. Buchman,, J. T. Seroky,, and P. Fireman. 1994. Nasal and otologic effects of experimental influenza A virus infection. Ann. Otol. Rhinol. Laryngol. 103: 59 69.
60. Doyle, W. J.,, D. P. Skoner,, M. White,, F. Hayden,, A. P. Kaplan,, M. A. Kaliner,, Y. Shibayama,, and P. Fireman. 1996. Pattern of nasal secretions during experimental influenza virus infection. Rhinology 34: 2 8.
61. El Ahmer, O. R.,, M. W. Raza,, M. M. Ogilvie,, D. M. Weir,, and C. C. Blackwell. 1999. Binding of bacteria to HEp-2 cells infected with influenza A virus. FEMS Immunol. Med. Microbiol. 23: 331 341.
62. Eskola, J.,, T. Kilpi,, A. Palmu,, J. Jokinen,, J. Haapakoski,, E. Herva,, A. Takala,, H. Kayhty,, P. Karma,, R. Kohberger,, G. Siber,, and P. H. Makela. 2001. Efficacy of a pneumococcal conjugate vaccine against acute otitis media. N. Engl. J. Med. 344: 403 409.
63. Faden, H. 2001. The microbiologic and immunologic basis for recurrent otitis media in children. Eur J Pediatr. 160: 407 413.
64. Faden, H.,, J. Bernstein,, L. Brodsky,, J. Stanievich,, and P. L. Ogra. 1992. Effect of prior antibiotic treatment on middle ear disease in children. Ann. Otol. Rhinol. Laryngol. 101: 87 91.
65. Faden, H.,, G. Doern,, J. Wolf,, and M. Blocker. 1994. Antimicrobial susceptibility of nasopharyngeal isolates of potential pathogens recovered from infants before antibiotic therapy: implications for the management of otitis media. Pediatr. Infect. Dis. J. 13: 609 612.
66. Faden, H.,, L. Duffy,, R. Wasielewski,, J. Wolf,, D. Krystofik,, Y. Tung, and Tonawanda/ Williamsville Pediatrics. 1997. Relationship between nasopharyngeal colonization and the development of otitis media in children. J. Infect. Dis. 175: 1440 1445.
67. Faden, H.,, L. Duffy,, A. Williams,, D. A. Krystofik,, and J. Wolf. 1995. Epidemiology of nasopharyngeal colonization with nontypeable Haemophilus influenzae in the first 2 years of life. J. Infect. Dis. 172: 132 135.
68. Faden, H. S. 1997. Immunology of the middle ear: role of local and systemic antibodies in clearance of viruses and bacteria. Ann. N. Y. Acad. Sci. 830: 49 60.
69. Fainstein, V.,, D. M. Musher,, and T. R. Cate. 1980. Bacterial adherence to pharyngeal cells during viral infection. J. Infect. Dis. 141: 172 176.
70. Fireman, P. 1990. The role of antihistamines in otitis. J. Allergy Clin. Immunol. 86: 638 641.
71. Foxwell, A. R.,, J. M. Kyd,, and A. W. Cripps. 1998. Nontypeable Haemophilus influenzae: pathogenesis and prevention. Microbiol. Mol. Biol. Rev. 62: 294 308.
72. Froom, J.,, L. Culpepper,, M. Jacobs,, R. A. DeMelker,, L. A. Green,, L. van Buchem,, P. Grob,, and T. Heeren. 1997. Antimicrobials for acute otitis media? A review from the International Primary Care Network. BMJ 315: 98 102.
73. Gates, G. A. 1999. Otitis media: the pharyngeal connection. JAMA 282: 987 989.
74. Gazagne, L.,, C. Delmas,, E. Bingen,, and H. Dabernat. 1998. Molecular epidemiology of ampicillin-resistant non-beta-lactamase-producing Haemophilus influenzae. J. Clin. Microbiol. 36: 3629 3635.
75. Gentile, D.,, W. Doyle,, T. Whiteside,, P. Fireman,, F. G. Hayden,, and D. Skoner. 1998. Increased interleukin-6 levels in nasal lavage samples following experimental influenza A virus infection. Clin. Diagn. Lab. Immunol. 5: 604 608.
76. Giebink, G. S. 1989. The microbiology of otitis media. Pediatr. Infect. Dis. J. 8: S18 S20.
77. Giebink, G. S. 1997. Vaccination against middle- ear bacterial and viral pathogens. Ann. N. Y. Acad. Sci. 830: 330 352.
78. Giebink, G. S.,, I. K. Berzins,, S. C. Marker,, and G. Schiffman. 1980. Experimental otitis media after nasal inoculation of Streptococcus pneumoniae and influenza A virus in chinchillas. Infect. Immun. 30: 445 450.
79. Giebink, G. S.,, E. L. Mills,, J. S. Huff,, K. L. Cates,, S. K. Juhn,, and P. G. Quie. 1979. Polymorphonuclear leukocyte dysfunction in children with recurrent otitis media. J. Pediatr. 94: 13 18.
80. Giebink, G. S.,, M. L. Ripley,, and P. F. Wright. 1987. Eustachian tube histopathology during experimental influenza A virus infection in the chinchilla. Ann. Otol. Rhinol. Laryngol. 96: 199 206.
81. Giebink, G. S.,, and P. F. Wright. 1983. Different virulence of influenza A virus strains and susceptibility to pneumococcal otitis media in chinchillas. Infect. Immun. 41: 913 920.
82. Glezen, W. P. 2000. Prevention of acute otitis media by prophylaxis and treatment of influenza virus infections. Vaccine 19( Suppl. 1): S56-– S58.
83. Gooch, W. M., 3rd, E. Blair, A. Puopolo, R. Z. Paster, R. H. Schwartz, H. C. Miller, H. L. Smyre, R. Yetman, G. G. Giguere, and J. J. Collins. 1996. Effectiveness of five days of therapy with cefuroxime axetil suspension for treatment of acute otitis media. Pediatr. Infect. Dis. J. 15: 157 164.
84. Green, M., and Wald, E. R. 1996. Emerging resistance to antibiotics: impact on respiratory infections in the outpatient setting. Ann. Allergy Asthma Immunol. 77: 167 173.
85. Gwaltney, J. M., Jr. 1971. Virology of middle ear. Ann. Otol. Rhinol. Laryngol. 80: 365 370.
86. Hakansson, A.,, A. Kidd,, G. Wadell,, H. Sabharwal,, and C. Svanborg. 1994. Adenovirus infection enhances in vitro adherence of Streptococcus pneumoniae. Infect. Immun. 62: 2707 2714.
87. Hament, J. M.,, J. L. Kimpen,, A. Fleer,, and T. F. Wolfs. 1999. Respiratory viral infection predisposing for bacterial disease: a concise review. FEMS Immunol. Med. Microbiol. 26: 189 195.
88. Harsten, G.,, K. Prellner,, B. Lofgren,, and O. Kalm. 1991. Serum antibodies against respiratory tract viruses in episodes of acute otitis media. J. Laryngol. Otol. 105: 337 340.
89. Hayden, F. G. 2000. Influenza virus and rhinovirus- related otitis media: potential for antiviral intervention. Vaccine 19( Suppl. 1): S66 S70.
90. Hayden, F. G.,, J. J. Treanor,, R. S. Fritz,, M. Lobo,, R. F. Betts,, M. Miller,, N. Kinnersley,, R. G. Mills,, P. Ward,, and S. E. Straus. 1999. Use of the oral neuraminidase inhibitor oseltamivir in experimental human influenza: randomized controlled trials for prevention and treatment. JAMA 282: 1240 1246.
91. Heikkinen, T. 2000. The role of respiratory viruses in otitis media. Vaccine 19( Suppl. 1): S51 S55.
92. Heikkinen, T. 2000. Role of viruses in the pathogenesis of acute otitis media. Pediatr. Infect. Dis. J. 19: S17 S22, S22 S23.
93. Heikkinen, T. 1994. Temporal development of acute otitis media during upper respiratory tract infection. Pediatr. Infect. Dis. J. 13: 659 661.
94. Heikkinen, T.,, and T. Chonmaitree. 2000. Viral-bacterial synergy in otitis media: implications for management. Curr. Infect. Dis. Rep. 2: 154 159.
95. Heikkinen, T.,, F. Ghaffar,, A. O. Okorodudu,, and T. Chonmaitree. 1998. Serum interleukin- 6 in bacterial and nonbacterial acute otitis media. Pediatrics 102: 296 299.
96. Heikkinen, T.,, O. Ruuskanen,, M. Waris,, T. Ziegler,, M. Arola,, and P. Halonen. 1991. Influenza vaccination in the prevention of acute otitis media in children. Am. J. Dis. Child. 145: 445 448.
97. Heikkinen, T.,, M. Thint,, and T. Chonmaitree. 1999. Prevalence of various respiratory viruses in the middle ear during acute otitis media. N. Engl. J. Med. 340: 260 264.
98. Henderson, F. W.,, A. M. Collier,, M. A. Sanyal,, J. M. Watkins,, D. L. Fairclough,, W. A. Clyde, Jr.,, and F. W. Denny. 1982. A longitudinal study of respiratory viruses and bacteria in the etiology of acute otitis media with effusion. N. Engl. J. Med. 306: 1377 1383.
99. Hendolin, P. H.,, A. Markkanen,, J. Ylikoski,, and J. J. Wahlfors. 1997. Use of multiplex PCR for simultaneous detection of four bacterial species in middle ear effusions. J. Clin. Microbiol. 35: 2854 2858.
100. Hendolin, P. H.,, L. Paulin,, and J. Ylikoski. 2000. Clinically applicable multiplex PCR for four middle ear pathogens. J. Clin. Microbiol. 38: 125 132.
101. Hirano, T.,, Y. Kurono,, I. Ichimiya,, M. Suzuki,, and G. Mogi. 1999. Effects of influenza A virus on lectin-binding patterns in murine nasopharyngeal mucosa and on bacterial colonization. Otolaryngol. Head Neck Surg. 121: 616 621.
102. Hotomi, M.,, T. Tabata,, H. Kakiuchi,, and M. Kunimoto. 1993. Detection of Haemophilus influenzae in middle ear of otitis media with effusion by polymerase chain reaction. Int. J. Pediatr. Otorhinolaryngol. 27: 119 126.
103. Hu, W. G.,, J. Chen,, F. M. Collins,, and X. X. Gu. 1999. An aerosol challenge mouse model for Moraxella catarrhalis. Vaccine 18: 799 804.
104. Hunter, L. L.,, R. H. Margolis,, and G. S. Giebink. 1994. Identification of hearing loss in children with otitis media. Ann. Otol. Rhinol. Laryngol. Suppl. 163: 59 61.
105. Infante-Rivard, C.,, and A. Fernandez. 1993. Otitis media in children: frequency, risk factors, and research avenues. Epidemiol. Rev. 15: 444 465.
106. Jakab, G. J. 1982. Viral-bacterial interactions in pulmonary infection. Adv. Vet. Sci. Comp. Med. 26: 155 171.
107. Jero, J.,, and P. Karma. 1997. Bacteriological findings and persistence of middle ear effusion in otitis media with effusion. Acta Oto-Laryngol. Suppl. 529: 22 66.
108. Jiang, Z.,, N. Nagata,, E. Molina,, L. O. Bakaletz,, H. Hawkins,, and J. A. Patel. 1999. Fimbria-mediated enhanced attachment of nontypeable Haemophilus influenzae to respiratory syncytial virus-infected respiratory epithelial cells. Infect. Immun. 67: 187 192.
109. Johnson, I. J.,, T. Brooks,, D. A. Hutton,, J. P. Birchall,, and J. P. Pearson. 1997. Compositional differences between bilateral middle ear effusions in otitis media with effusion: evidence for a different etiology? Laryngoscope 107: 684 689.
110. Johnson, M.,, G. Leonard,, and D. L. Kreutzer. 1997. Murine model of interleukin- 8-induced otitis media. Laryngoscope 107: 1405 1408.
111. Jossart, G. H.,, D. M. Canafax,, G. R. Erdmann,, M. J. Lovdahl,, H. Q. Russlie,, S. K. Juhn,, and G. S. Giebink. 1994. Effect of Streptococcus pneumoniae and influenza A virus on middle ear antimicrobial pharmacokinetics in experimental otitis media. Pharm. Res. 11: 860 864.
112. Jung, T. T. 1988. Arachidonic acid metabolites in otitis media pathogenesis. Ann. Otol. Rhinol. Laryngol. 132( Suppl.): 14 18.
113. Jung, T. T.,, D. M. Smith,, S. K. Juhn,, and J. M. Gerrard. 1980. Effect of prostaglandin on the composition of chinchilla middle ear effusion. Ann. Otol. Rhinol. Laryngol. 89( Suppl.): 153 160.
114. Kaplan, B.,, T. L. Wandstrat,, and J. R. Cunningham. 1997. Overall cost in the treatment of otitis media. Pediatr. Infect. Dis. J. 16: S9 S11.
115. Karalus, R.,, and A. Campagnari. 2000. Moraxella catarrhalis: a review of an important human mucosal pathogen. Microb. Infect. 2: 547 559.
116. Kawana, M.,, C. Kawana,, and G. S. Giebink. 1992. Penicillin treatment accelerates middle ear inflammation in experimental pneumococcal otitis media. Infect. Immun. 60: 1908 1912.
117. Kennedy, B. J.,, L. A. Novotny,, J. A. Jurcisek,, Y. Lobet,, and L. O. Bakaletz. 2000. Passive transfer of antiserum specific for immunogens derived from a nontypeable Haemophilus influenzae adhesin and lipoprotein D prevents otitis media after heterologous challenge. Infect. Immun. 68: 2756 2765.
118. Klein, B. S.,, F. R. Dollete,, and R. H. Yolken. 1982. The role of respiratory syncytial virus and other viral pathogens in acute otitis media. J. Pediatr. 101: 16 20.
119. Klein, J. O.,, and D. W. Teele. 1976. Isolation of viruses and mycoplasmas from middle ear effusions: a review. Ann. Otol. Rhinol. Laryngol. 85: 140 144.
120. Kodama, S.,, S. Suenaga,, T. Hirano,, M. Suzuki,, and G. Mogi. 2000. Induction of specific immunoglobulin A and Th2 immune responses to P6 outer membrane protein of nontypeable Haemophilus influenzae in middle ear mucosa by intranasal immunization. Infect. Immun. 68: 2294 2300.
121. Koivunen, P.,, T. Kontiokari,, M. Niemela,, T. Pokka,, and M. Uhari. 1999. Time to development of acute otitis media during an upper respiratory tract infection in children. Pediatr. Infect. Dis. J. 18: 303 305.
122. Korppi, M.,, M. Leinonen,, M. Koskela,, P. H. Makela,, and K. Launiala. 1989. Bacterial coinfection in children hospitalized with respiratory syncytial virus infections. Pediatr. Infect. Dis. J. 8: 687 692.
123. Korppi, M.,, M. Leinonen,, P. H. Makela,, and K. Launiala. 1991. Mixed infection is common in children with respiratory adenovirus infection. Acta Paediatr. Scand. 80: 413 417.
124. Kozyrskyj, A. L.,, G. E. Hildes-Ripstein,, S. E. Longstaffe,, J. L. Wincott,, D. S. Sitar,, T. P. Klassen,, and M. E. Moffatt. 1998. Treatment of acute otitis media with a shortened course of antibiotics: a meta-analysis. JAMA 279: 1736 1742.
125. Kurono, Y.,, M. Yamamoto,, K. Fujihashi,, S. Kodama,, M. Suzuki,, G. Mogi,, J. R. McGhee,, and H. Kiyono. 1999. Nasal immunization induces Haemophilus influenzae-specific Th1 and Th2 responses with mucosal IgA and systemic IgG antibodies for protective immunity. J. Infect. Dis. 180: 122 132.
126. Kvaerner, K. J.,, P. Nafstad,, J. Hagen,, I. W. Mair,, and J. J. Jaakkola. 1997. Early acute otitis media: determined by exposure to respiratory pathogens. Acta Otolaryngol. Suppl. 529: 14 18.
127. Kyd, J. M.,, and A. W. Cripps. 1999. Killed whole bacterial cells, a mucosal delivery system for the induction of immunity in the respiratory tract and middle ear: an overview. Vaccine 17: 1775 1781.
128. LaMarco, K. L.,, W. F. Diven,, and R. H. Glew. 1986. Experimental alteration of chinchilla middle ear mucosae by bacterial neuraminidase. Ann. Otol. Rhinol. Laryngol. 95: 304 308.
129. Liederman, E. M.,, J. C. Post,, J. J. Aul,, D. A. Sirko,, G. J. White,, C. A. Buchman,, and G. D. Ehrlich. 1998. Analysis of adult otitis media: polymerase chain reaction versus culture for bacteria and viruses. Ann. Otol. Rhinol. Laryngol. 107: 10 16.
130. Linder, T. E.,, R. L. Daniels,, D. J. Lim,, and T. F. DeMaria. 1994. Effect of intranasal inoculation of Streptococcus pneumoniae on the structure of the surface carbohydrates of the chinchilla eustachian tube and middle ear mucosa. Microb. Pathog. 16: 435 441.
131. Linder, T. E.,, D. J. Lim,, and T. F. De- Maria. 1992. Changes in the structure of the cell surface carbohydrates of the chinchilla tubotympanum following Streptococcus pneumoniae-induced otitis media. Microb. Pathog. 13: 293 303.
132. Luce, B. R.,, K. M. Zangwill,, C. S. Palmer,, P. M. Mendelman,, L. Yan,, M. C. Wolff,, I. Cho,, S. M. Marcy,, D. Iacuzio,, and R. B. Belshe. 2001. Cost-effectiveness analysis of an intranasal influenza vaccine for the prevention of influenza in healthy children. Pediatrics 108: E24.
133. Mackowiak, P. A. 1978. Microbial synergism in human infections (first of two parts) N. Engl. J. Med. 298: 21 26.
134. Mah, T. F.,, and G. A. O’Toole. 2001. Mechanisms of biofilm resistance to antimicrobial agents. Trends Microbiol. 9: 34 39.
135. Mandel, E. M.,, H. E. Rockette,, C. D. Bluestone,, J. L. Paradise,, and R. J. Nozza. 1987. Efficacy of amoxicillin with and without decongestant-antihistamine for otitis media with effusion in children. Results of a double-blind, randomized trial. N. Engl. J. Med. 316: 432 437.
136. Matsuda, K.,, H. Tsutsumi,, Y. Okamoto,, and C. Chiba. 1995. Development of interleukin 6 and tumor necrosis factor alpha activity in nasopharyngeal secretions of infants and children during infection with respiratory syncytial virus. Clin. Diagn. Lab. Immunol. 2: 322 324.
137. McBride, T. P.,, W. J. Doyle,, F. G. Hayden,, and J. M. Gwaltney, Jr. 1989. Alterations of the eustachian tube, middle ear, and nose in rhinovirus infection. Arch. Otolaryngol. Head Neck Surg. 115: 1054 1059.
138. McIntosh, K.,, P. Halonen,, and O. Ruuskanen. 1993. Report of a workshop on respiratory viral infections: epidemiology, diagnosis, treatment, and prevention. Clin. Infect. Dis. 16: 151 164.
139. McLinn, S.,, and D. Williams. 1996. Incidence of antibiotic-resistant Streptococcus pneumoniae and beta-lactamase-positive Haemophilus influenzae in clinical isolates from patients with otitis media. Pediatr. Infect. Dis. J. 15: S3-– S9.
140. Melhus, A.,, and A. F. Ryan. 2000. Expression of cytokine genes during pneumococcal and nontypeable Haemophilus influenzae acute otitis media in the rat. Infect. Immun. 68: 4024 4031.
141. Michon, F.,, P. C. Fusco,, C. A. Minetti,, M. Laude-Sharp,, C. Uitz,, C. H. Huang,, A. J. D’Ambra,, S. Moore,, D. P. Remeta,, I. Heron,, and M. S. Blake. 1998. Multivalent pneumococcal capsular polysaccharide conjugate vaccines employing genetically detoxified pneumolysin as a carrier protein. Vaccine 16: 1732 1741.
142. Miura, M.,, H. Takahashi,, I. Honjo,, S. Hasebe,, and M. Tanabe. 1997. Influence of the upper respiratory tract infection on tubal compliance in children with otitis media with effusion. Acta Otolaryngol. 117: 574 577.
143. Miyamoto, N.,, and L. O. Bakaletz. 1997. Kinetics of the ascension of NTHi from the nasopharynx to the middle ear coincident with adenovirus-induced compromise in the chinchilla. Microb. Pathog. 23: 119 126.
144. Miyamoto, N.,, and L. O. Bakaletz. 1996. Selective adherence of non-typeable Haemophilus influenzae (NTHi) to mucus or epithelial cells in the chinchilla eustachian tube and middle ear. Microb. Pathog. 21: 343 356.
145. Narkio-Makela, M.,, J. Jero,, and S. Meri. 1999. Complement activation and expression of membrane regulators in the middle ear mucosa in otitis media with effusion. Clin. Exp. Immunol. 116: 401 409.
146. Nelson, C. T.,, E. O. Mason, Jr.,, and S. L. Kaplan. 1994. Activity of oral antibiotics in middle ear and sinus infections caused by penicillin- resistant Streptococcus pneumoniae: implications for treatment. Pediatr. Infect. Dis. J. 13: 585 589.
147. Noah, T. L.,, F. W. Henderson,, I. A. Wortman,, R. B. Devlin,, J. Handy,, H. S. Koren,, and S. Becker. 1995. Nasal cytokine production in viral acute upper respiratory infection of childhood. J. Infect. Dis. 171: 584 592.
148. Ogra, P. L.,, H. Faden,, and R. C. Welliver. 2001. Vaccination strategies for mucosal immune responses. Clin. Microbiol. Rev. 14: 430 445.
149. Ohashi, Y.,, Y. Nakai,, Y. Esaki,, H. Ikeoka,, and H. Koshimo. 1988. Effects of bacterial endotoxin on ciliary activity in the tubotympanum. Ann. Otol. Rhinol. Laryngol. 97: 298 301.
150. Ohashi, Y.,, Y. Nakai,, Y. Esaki,, Y. Ohno,, Y. Sugiura,, and H. Okamoto. 1991. Influenza A virus-induced otitis media and mucociliary dysfunction in the guinea pig. Acta Otolaryngol. Suppl. 486: 135 148.
151. Okamoto, Y.,, K. Kudo,, K. Ishikawa,, E. Ito,, K. Togawa,, I. Saito,, I. Moro,, J. A. Patel,, and P. L. Ogra. 1993. Presence of respiratory syncytial virus genomic sequences in middle ear fluid and its relationship to expression of cytokines and cell adhesion molecules. J. Infect. Dis. 168: 1277 1281.
152. Okamoto, Y.,, K. Kudo,, K. Shirotori,, M. Nakazawa,, E. Ito,, K. Togawa,, J. A. Patel,, and P. L. Ogra. 1992. Detection of genomic sequences of respiratory syncytial virus in otitis media with effusion in children. Ann. Otol. Rhinol. Laryngol. 157( Suppl.): 7 10.
153. Paap, C. M. 1996. Management of otitis media with effusion in young children. Ann. Pharmacother. 30: 1291 1297.
154. Paradise, J. L.,, H. E. Rockette,, D. K. Colborn,, B. S. Bernard,, C. G. Smith,, M. Kurs-Lasky,, and J. E. Janosky. 1997. Otitis media in 2253 Pittsburgh-area infants: prevalence and risk factors during the first two years of life. Pediatrics 99: 318 333.
155. Park, K.,, L. O. Bakaletz,, J. M. Coticchia,, and D. J. Lim. 1993. Effect of influenza A virus on ciliary activity and dye transport function in the chinchilla eustachian tube. Ann. Otol. Rhinol. Laryngol. 102: 551 558.
156. Patel, J.,, H. Faden,, S. Sharma,, and P. L. Ogra. 1992. Effect of respiratory syncytial virus on adherence, colonization and immunity of non-typable Haemophilus influenzae: implications for otitis media. Int. J. Pediatr. Otorhinolaryngol. 23: 15 23.
157. Patel, J. A.,, B. Reisner,, N. Vizirinia,, M. Owen,, T. Chonmaitree,, and V. Howie. 1995. Bacteriologic failure of amoxicillin-clavulanate in treatment of acute otitis media caused by nontypeable Haemophilus influenzae. J. Pediatr. 126: 799 806.
158. Persson, C. G.,, I. Erjefalt,, U. Alkner,, C. Baumgarten,, L. Greiff,, B. Gustafsson,, A. Luts,, U. Pipkorn,, F. Sundler,, C. Svensson,, and P. Wollmer. 1991. Plasma exudation as a first line respiratory mucosal defence. Clin. Exp. Allergy 21: 17 24.
159. Pichichero, M. E. 1998. Changing the treatment paradigm for acute otitis media in children JAMA 279: 1748 1750.
160. Pichichero, M. E.,, and C. L. Pichichero. 1995. Persistent acute otitis media: I. Causative pathogens. Pediatr. Infect. Dis. J. 14: 178 183.
161. Pitkaranta, A.,, J. Jero,, E. Arruda,, A. Virolainen,, and F. G. Hayden. 1998. Polymerase chain reaction-based detection of rhinovirus, respiratory syncytial virus, and coronavirus in otitis media with effusion. J. Pediatr. 133: 390 394.
162. Pitkaranta, A.,, A. Virolainen,, J. Jero,, E. Arruda,, and F. G. Hayden. 1998. Detection of rhinovirus, respiratory syncytial virus, and coronavirus infections in acute otitis media by reverse transcriptase polymerase chain reaction. Pediatrics 102: 291 295.
163. Plotkowski, M. C.,, E. Puchelle,, G. Beck,, J. Jacquot,, and C. Hannoun. 1986. Adherence of type I Streptococcus pneumoniae to tracheal epithelium of mice infected with influenza A/PR8 virus. Am. Rev. Respir. Dis. 134: 1040 1044.
164. Poolman, J. T.,, L. Bakaletz,, A. Cripps,, P. A. Denoel,, A. Forsgren,, J. Kyd,, and Y. Lobet. 2000. Developing a nontypeable Haemophilus influenzae (NTHi) vaccine. Vaccine 19( Suppl 1): S108 S115.
165. Post, J. C.,, J. J. Aul,, G. J. White,, R. M. Wadowsky,, T. Zavoral,, R. Tabari,, B. Kerber,, W. J. Doyle,, and G. D. Ehrlich. 1996. PCR-based detection of bacterial DNA after antimicrobial treatment is indicative of persistent, viable bacteria in the chinchilla model of otitis media. Am. J. Otolaryngol. 17: 106 111.
166. Post, J. C.,, M. Ehrlich,, and G. D. Ehrlich. 2000. Otitis media with effusion as a bacterial biofilm disease, p. 1 37. In New Paradigms in Infectious Disease: Applications to Otitis Media, October 13-15, 2000, Pittsburgh, Pa..
167. Post, J. C.,, R. A. Preston,, J. J. Aul,, M. Larkins-Pettigrew,, J. Rydquist-White,, K. W. Anderson,, R. M. Wadowsky,, D. R. Reagan,, E. S. Walker,, L. A. Kingsley, et al. 1995. Molecular analysis of bacterial pathogens in otitis media with effusion. JAMA 273: 1598 1604.
168. Post, J. C.,, G. J. White,, J. J. Aul,, T. Zavoral,, R. M. Wadowsky,, Y. Zhang,, R. A. Preston,, and G. D. Ehrlich. 1996. Development and validation of a multiplex PCR-based assay for the upper respiratory tract bacterial pathogens Haemophilus influenzae, Streptococcus pneumoniae, and Moraxella catarrhalis. Mol. Diagn. 1: 29 39.
169. Potera, C. 1999. Forging a link between biofilms and disease. Science 283: 1837 1839.
170. Rayner, M. G.,, Y. Zhang,, M. C. Gorry,, Y. Chen,, J. C. Post,, and G. D. Ehrlich. 1998. Evidence of bacterial metabolic activity in culture- negative otitis media with effusion. JAMA 279: 296 299.
171. Reisinger, K.,, F. Hayden,, R. Whitley,, R. Dutkowski,, D. Ipe,, R. Mills,, and P. Ward. 2000. Oral oseltamivir is effective and safe in the treatment of children with acute influenza. Clin. Microbiol. Infect. 6( Suppl. 1): 250.
172. Richter, S. S.,, P. L. Winokur,, A. B. Brueggemann,, H. K. Huynh,, P. R. Rhomberg,, E. M. Wingert,, and G. V. Doern. 2000. Molecular characterization of the beta-lactamases from clinical isolates of Moraxella (Branhamella) catarrhalis obtained from 24 U.S. medical centers during 1994-1995 and 1997-1998. Antimicrob. Agents Chemother. 44: 444 446.
173. Ruohola, A.,, T. Heikkinen,, J. Jero,, T. Puhakka,, T. Juven,, M. Narkio-Makela,, H. Saxen,, and O. Ruuskanen. 1999. Oral prednisolone is an effective adjuvant therapy for acute otitis media with discharge through tympanostomy tubes. J. Pediatr. 134: 459 463.
174. Ruohola, A.,, T. Heikkinen,, M. Waris,, T. Puhakka,, and O. Ruuskanen. 2000. Intranasal fluticasone propionate does not prevent acute otitis media during viral upper respiratory infection in children. J. Allergy Clin. Immunol. 106: 467 471.
175. Ruuskanen, O.,, M. Arola,, T. Heikkinen,, and T. Ziegler. 1991. Viruses in acute otitis media: increasing evidence for clinical significance. Pediatr. Infect. Dis. J. 10: 425 427.
176. Ruuskanen, O.,, M. Arola,, A. Putto-Laurila,, J. Mertsola,, O. Meurman,, M. K. Viljanen,, and P. Halonen. 1989. Acute otitis media and respiratory virus infections. Pediatr. Infect. Dis. J. 8: 94 99.
177. Ruuskanen, O.,, and T. Heikkinen. 1994. Viral-bacterial interaction in acute otitis media. Pediatr. Infect. Dis. J. 13: 1047 1049.
178. Saidi, I. S.,, J. F. Biedlingmaier,, and P. Whelan. 1999. In vivo resistance to bacterial biofilm formation on tympanostomy tubes as a function of tube material. Otolaryngol. Head Neck Surg. 120: 621 627.
179. Sanford, B. A.,, A. Shelokov,, and M. A. Ramsay. 1978. Bacterial adherence to virus-infected cells: a cell culture model of bacterial superinfection. J. Infect. Dis. 137: 176 181.
180. Sarkkinen, H.,, O. Ruuskanen,, O. Meurman,, H. Puhakka,, E. Virolainen,, and J. Eskola. 1985. Identification of respiratory virus antigens in middle ear fluids of children with acute otitis media. J. Infect. Dis. 151: 444 448.
181. Sarkkinen, H. K.,, P. E. Halonen,, P. P. Arstila,, and A. A. Salmi. 1981. Detection of respiratory syncytial, parainfluenza type 2, and adenovirus antigens by radioimmunoassay and enzyme immunoassay on nasopharyngeal specimens from children with acute respiratory disease. J. Clin. Microbiol. 13: 258 265.
182. Sarkkinen, H. K.,, O. Meurman,, T. T. Salmi,, H. Puhakka,, and E. Virolainen. 1983. Demonstration of viral antigens in middle ear secretions of children with acute otitis media Acta Paediatr. Scand. 72: 137 138.
183. Sato, K.,, C. L. Liebeler,, M. K. Quartey,, C. T. Le,, and G. S. Giebink. 1999. Middle ear fluid cytokine and inflammatory cell kinetics in the chinchilla otitis media model. Infect. Immun. 67: 1943 1946.
184. Shaw, C. B.,, N. Obermyer,, S. J. Wetmore,, G. A. Spirou,, and R. W. Farr. 1995. Incidence of adenovirus and respiratory syncytial virus in chronic otitis media with effusion using the polymerase chain reaction. Otolaryngol. Head Neck Surg. 113: 234 241.
185. Siegrist, C. A. 2000. Vaccination in the neonatal period and early infancy. Int. Rev. Immunol. 19: 195 219.
186. Simoes, E. A.,, J. R. Groothuis,, D. A. Tristram,, K. Allessi,, M. V. Lehr,, G. R. Siber,, and R. C. Welliver. 1996. Respiratory syncytial virus-enriched globulin for the prevention of acute otitis media in high risk children. J. Pediatr. 129: 214 219.
187. Sirakova, T.,, P. E. Kolattukudy,, D. Murwin,, J. Billy,, E. Leake,, D. Lim,, T. De- Maria,, and L. Bakaletz. 1994. Role of fimbriae expressed by nontypeable Haemophilus influenzae in pathogenesis of and protection against otitis media and relatedness of the fimbrin subunit to outer membrane protein A. Infect. Immun. 62: 2002 2020.
188. Stenfors, L. E.,, and S. Raisanen. 1989. Presence of Branhamella catarrhalis alters the survival of Streptococcus pneumoniae and Haemophilus influenzae in middle ear effusion: an in vitro study. J. Laryngol. Otol. 103: 1030 1033.
189. Stool, S. E.,, A. O. Berg,, S. Berman,, C. J. Carney,, J. R. Cooley,, L. Culpepper,, R. D. Eavey,, L. V. Feagans,, T. Finitzo,, E. M. Friedman,, J. A. Goertz,, A. J. Goldstein,, K. M. Grundfast,, D. G. Long,, L. L. Macconi,, L. Melton,, J. E. Roberts,, J. L. Sherrod,, and J. E. Sisk. 1994. Otitis Media with Effusion in Young Children. Clinical Practice Guideline, vol. 12. Agency for Health Care Policy and Research, Public Health Service, U.S. Department of Health and Human Services, Rockville, Md..
190. Sung, B. S.,, T. Chonmaitree,, L. D. Broemeling,, M. J. Owen,, J. A. Patel,, D. C. Hedgpeth,, and V. M. Howie. 1993. Association of rhinovirus infection with poor bacteriologic outcome of bacterial-viral otitis media. Clin. Infect. Dis. 17: 38 42.
191. Sutbeyaz, Y.,, B. Yakan,, H. Ozdemir,, M. Karasen,, F. Doner,, and I. Kufrevioglu. 1996. Effect of SC-41930, a potent selective leukotriene B4 receptor antagonist, in the guinea pig model of middle ear inflammation. Ann. Otol. Rhinol. Laryngol. 105: 476 480.
192. Suzuki, K.,, and L. O. Bakaletz. 1994. Synergistic effect of adenovirus type 1 and nontypeable Haemophilus influenzae in a chinchilla model of experimental otitis media. Infect. Immun. 62: 1710 1718.
193. Swarts, J. D.,, J. Y. Westcott,, and K. H. Chan. 1997. Eicosanoid synthesis and inactivation in healthy and infected chinchilla middle ears. Acta Otolaryngol. (Stockholm) 117: 845 850.
194. Teele, D. W.,, J. O. Klein,, C. Chase,, P. Menyuk,, B. A. Rosner, and the Greater Boston Otitis Media Study Group. 1990. Otitis media in infancy and intellectual ability, school achievement, speech, and language at age 7 years. J. Infect. Dis. 162: 685 694.
195. Teele, D. W.,, J. O. Klein,, and B. Rosner. 1989. Epidemiology of otitis media during the first seven years of life in children in greater Boston: a prospective, cohort study. J. Infect. Dis. 160: 83 94.
196. Tejani, N. R.,, T. Chonmaitree,, D. K. Rassin,, V. M. Howie,, M. J. Owen,, and A. S. Goldman. 1995. Use of C-reactive protein in differentiation between acute bacterial and viral otitis media. Pediatrics 95: 664 669.
197. Tong, H. H.,, L. M. Fisher,, G. M. Kosunick,, and T. F. DeMaria. 2000. Effect of adenovirus type 1 and influenza A virus on Streptococcus pneumoniae nasopharyngeal colonization and otitis media in the chinchilla. Ann. Otol. Rhinol. Laryngol. 109: 1021 1027.
198. Tong, H. H.,, J. N. Weiser,, M. A. James,, and T. F. DeMaria. 2001. Effect of influenza A virus infection on nasopharyngeal colonization and otitis media induced by transparent or opaque phenotype variants of Streptococcus pneumoniae in the chinchilla model. Infect. Immun. 69: 602 606.
199. Turner, R. B. 2001. The treatment of rhinovirus infections: progress and potential. Antivir. Res. 49: 1 14.
200. Turner, R. B.,, M. T. Wecker,, G. Pohl,, T. J. Witek,, E. McNally,, R. St George,, B. Winther,, and F. G. Hayden. 1999. Efficacy of tremacamra, a soluble intercellular adhesion molecule 1, for experimental rhinovirus infection: a randomized clinical trial. JAMA 281: 1797 1804.
201. Ueyama, T.,, Y. Kurono,, K. Shirabe,, M. Takeshita,, and G. Mogi. 1995. High incidence of Haemophilus influenzae in nasopharyngeal secretions and middle ear effusions as detected by PCR. J. Clin. Microbiol. 33: 1835 1838.
202. Uhari, M.,, J. Hietala,, and H. Tuokko. 1995. Risk of acute otitis media in relation to the viral etiology of infections in children. Clin. Infect. Dis. 20: 521 524.
203. Underdown, B. J.,, and S. A. Plotkin. 1999. The induction of mucosal protection by parenteral immunization: a challenge to the mucosal immunity paradigm, p. 719 728, Mucosal Immunology. Academic Press, Inc., New York, N.Y..
204. Unhanand, M.,, I. Maciver,, O. Ramilo,, O. Arencibia-Mireles,, J. C. Argyle,, G. H. Mc- Cracken, Jr.,, and E. J. Hansen. 1992. Pul- monary clearance of Moraxella catarrhalis in an animal model. J. Infect. Dis. 165: 644 650.
205. Valiante, N. M.,, R. Rappuoli,, R. A. Insel,, P. McInnes,, and A. Hoeveler. 1999. The challenges of vaccinating the very young: lessons from a very old system of host defense. Vaccine. 17: 2757 2762.
206. van Buchem, F. L.,, M. F. Peeters,, and M. A. van’t Hof. 1985. Acute otitis media: a new treatment strategy. Br. Med. J. 290: 1033 1037.
207. vander Ven, L. T.,, G. P. van den Dobbelsteen,, B. Nagarajah,, H. van Dijken,, P. M. Dortant,, J. G. Vos,, and P. J. Roholl. 1999. A new rat model of otitis media caused by Streptococcus pneumoniae: conditions and application in immunization protocols. Infect. Immun. 67: 6098 6103.
208. Virolainen, A.,, P. Salo,, J. Jero,, P. Karma,, J. Eskola,, and M. Leinonen. 1994. Comparison of PCR assay with bacterial culture for detecting Streptococcus pneumoniae in middle ear fluid of children with acute otitis media. J. Clin. Microbiol. 32: 2667 2670.
209. Wadowsky, R. M.,, S. M. Mietzner,, D. P. Skoner,, W. J. Doyle,, and P. Fireman. 1995. Effect of experimental influenza A virus infection on isolation of Streptococcus pneumoniae and other aerobic bacteria from the oropharynges of allergic and nonallergic adult subjects. Infect. Immun. 63: 1153 1157.
210. Wang, E. E.,, T. R. Einarson,, J. D. Kellner,, and J. M. Conly. 1999. Antibiotic prescribing for Canadian preschool children: evidence of overprescribing for viral respiratory infections. Clin. Infect. Dis. 29: 155 160.
211. Warshauer, D.,, E. Goldstein,, T. Akers,, W. Lippert,, and M. Kim. 1977. Effect of influenza viral infection on the ingestion and killing of bacteria by alveolar macrophages. Am. Rev. Respir. Dis. 115: 269 277.
212. Westman, E. B.,, A. Hermansson,, K. Prellner,, A. Melhus,, and S. Hellstrom,. 1994. Moraxella catarrhalis-induced purulent otitis media in the rat middle ear, p. 193 195. In G. Mogi,, I. Honjo,, T. Ishii,, and T. Takasaka (ed.), Second Extraordinary International Symposium on Recent Advances in Otitis Media. Kugler Publications, Amsterdam, The Netherlands.
213. Willett, D. N.,, R. P. Rezaee,, J. M. Billy,, M. B. Tighe,, and T. F. DeMaria. 1998. Relationship of endotoxin to tumor necrosis factoralpha and interleukin-1 beta in children with otitis media with effusion. Ann. Otol. Rhinol. Laryngol. 107: 28 33.
214. Williams, R. L.,, T. C. Chalmers,, K. C. Stange,, F. T. Chalmers,, and S. J. Bowlin. 1993. Use of antibiotics in preventing recurrent acute otitis media and in treating otitis media with effusion. A meta-analytic attempt to resolve the brouhaha. JAMA 270: 1344 1351. ( Erratum, 271:430, 1994.).
215. Yellon, R. F.,, W. J. Doyle,, T. L. Whiteside,, W. F. Diven,, A. R. March,, and P. Fireman. 1995. Cytokines, immunoglobulins, and bacterial pathogens in middle ear effusions. Arch. Otolaryngol. Head Neck Surg. 121: 865 869 ( Erratum, 121:1402).

Tables

Generic image for table
TABLE 1

Comparison of clinical and bacteriologic outcome of patients with AOM caused by bacteria alone or bacteria and virus

Citation: Bakaletz L. 2002. Otitis Media, p 259-298. In Brogden K, Guthmiller J (ed), Polymicrobial Diseases. ASM Press, Washington, DC. doi: 10.1128/9781555817947.ch14
Generic image for table
TABLE 2

Dye transport values for chinchillas injected transbullarly with influenza A/Alaska/6/77 virus

Citation: Bakaletz L. 2002. Otitis Media, p 259-298. In Brogden K, Guthmiller J (ed), Polymicrobial Diseases. ASM Press, Washington, DC. doi: 10.1128/9781555817947.ch14
Generic image for table
TABLE 3

Demographic information on 186 participants in influenza-OM trial

Citation: Bakaletz L. 2002. Otitis Media, p 259-298. In Brogden K, Guthmiller J (ed), Polymicrobial Diseases. ASM Press, Washington, DC. doi: 10.1128/9781555817947.ch14
Generic image for table
TABLE 4

Percentage of infants with AOM and SOM infections before, during, and after influenza season

Citation: Bakaletz L. 2002. Otitis Media, p 259-298. In Brogden K, Guthmiller J (ed), Polymicrobial Diseases. ASM Press, Washington, DC. doi: 10.1128/9781555817947.ch14

This is a required field
Please enter a valid email address
Please check the format of the address you have entered.
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error